The effect of fluvoxamine, cognitive therapy, and placebo on abnormal personality traits in 44 patients with panic disorder

Donald W. Black, Patrick Monahan, Robert Wesner, Janelle Gabel, Wayne Bowers

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The authors report findings from 44 outpatients with panic disorder who completed an 8 week randomized trial of fluvoxamine (n = 17), cognitive therapy (n = 13), or placebo (n = 14). Subjects were given the Personality Diagnostic Questionnaire-Revised (PDQ-R) before and after the trial. Patients in the three treatment cells were well matched. Nearly 32% met criteria for a personality disorder at the baseline assessment, and there were no significant differences among the treatment groups. For the 3 groups combined, the total PDQ-R score had declined significantly by week 8 (p = .03). Of the 17 PDQ-R traits present in at least 1/3 of the sample, 82% showed a decline in the cognitive therapy cell, whereas 53% did not change in the fluvoxamine cell and 41% increased in the placebo cell. 'Personality profiles' were created and showed that cognitive therapy was associated with the greatest reduction in abnormal traits, specifically those in the schizotypal, narcissistic, borderline, and compulsive categories. Axis II traits were relatively resistant to change with placebo or fluvoxamine. The clinical implications of the findings are discussed.

Original languageEnglish (US)
Pages (from-to)185-194
Number of pages10
JournalJournal of Personality Disorders
Volume10
Issue number2
StatePublished - Jun 1996
Externally publishedYes

Fingerprint

Fluvoxamine
Panic Disorder
Cognitive Therapy
Personality
Placebos
Personality Disorders
Outpatients
Therapeutics
Surveys and Questionnaires

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The effect of fluvoxamine, cognitive therapy, and placebo on abnormal personality traits in 44 patients with panic disorder. / Black, Donald W.; Monahan, Patrick; Wesner, Robert; Gabel, Janelle; Bowers, Wayne.

In: Journal of Personality Disorders, Vol. 10, No. 2, 06.1996, p. 185-194.

Research output: Contribution to journalArticle

@article{f7ac1e0d03d04358b71df115449ed85e,
title = "The effect of fluvoxamine, cognitive therapy, and placebo on abnormal personality traits in 44 patients with panic disorder",
abstract = "The authors report findings from 44 outpatients with panic disorder who completed an 8 week randomized trial of fluvoxamine (n = 17), cognitive therapy (n = 13), or placebo (n = 14). Subjects were given the Personality Diagnostic Questionnaire-Revised (PDQ-R) before and after the trial. Patients in the three treatment cells were well matched. Nearly 32{\%} met criteria for a personality disorder at the baseline assessment, and there were no significant differences among the treatment groups. For the 3 groups combined, the total PDQ-R score had declined significantly by week 8 (p = .03). Of the 17 PDQ-R traits present in at least 1/3 of the sample, 82{\%} showed a decline in the cognitive therapy cell, whereas 53{\%} did not change in the fluvoxamine cell and 41{\%} increased in the placebo cell. 'Personality profiles' were created and showed that cognitive therapy was associated with the greatest reduction in abnormal traits, specifically those in the schizotypal, narcissistic, borderline, and compulsive categories. Axis II traits were relatively resistant to change with placebo or fluvoxamine. The clinical implications of the findings are discussed.",
author = "Black, {Donald W.} and Patrick Monahan and Robert Wesner and Janelle Gabel and Wayne Bowers",
year = "1996",
month = "6",
language = "English (US)",
volume = "10",
pages = "185--194",
journal = "Journal of Personality Disorders",
issn = "0885-579X",
publisher = "Guilford Publications",
number = "2",

}

TY - JOUR

T1 - The effect of fluvoxamine, cognitive therapy, and placebo on abnormal personality traits in 44 patients with panic disorder

AU - Black, Donald W.

AU - Monahan, Patrick

AU - Wesner, Robert

AU - Gabel, Janelle

AU - Bowers, Wayne

PY - 1996/6

Y1 - 1996/6

N2 - The authors report findings from 44 outpatients with panic disorder who completed an 8 week randomized trial of fluvoxamine (n = 17), cognitive therapy (n = 13), or placebo (n = 14). Subjects were given the Personality Diagnostic Questionnaire-Revised (PDQ-R) before and after the trial. Patients in the three treatment cells were well matched. Nearly 32% met criteria for a personality disorder at the baseline assessment, and there were no significant differences among the treatment groups. For the 3 groups combined, the total PDQ-R score had declined significantly by week 8 (p = .03). Of the 17 PDQ-R traits present in at least 1/3 of the sample, 82% showed a decline in the cognitive therapy cell, whereas 53% did not change in the fluvoxamine cell and 41% increased in the placebo cell. 'Personality profiles' were created and showed that cognitive therapy was associated with the greatest reduction in abnormal traits, specifically those in the schizotypal, narcissistic, borderline, and compulsive categories. Axis II traits were relatively resistant to change with placebo or fluvoxamine. The clinical implications of the findings are discussed.

AB - The authors report findings from 44 outpatients with panic disorder who completed an 8 week randomized trial of fluvoxamine (n = 17), cognitive therapy (n = 13), or placebo (n = 14). Subjects were given the Personality Diagnostic Questionnaire-Revised (PDQ-R) before and after the trial. Patients in the three treatment cells were well matched. Nearly 32% met criteria for a personality disorder at the baseline assessment, and there were no significant differences among the treatment groups. For the 3 groups combined, the total PDQ-R score had declined significantly by week 8 (p = .03). Of the 17 PDQ-R traits present in at least 1/3 of the sample, 82% showed a decline in the cognitive therapy cell, whereas 53% did not change in the fluvoxamine cell and 41% increased in the placebo cell. 'Personality profiles' were created and showed that cognitive therapy was associated with the greatest reduction in abnormal traits, specifically those in the schizotypal, narcissistic, borderline, and compulsive categories. Axis II traits were relatively resistant to change with placebo or fluvoxamine. The clinical implications of the findings are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0030016864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030016864&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 185

EP - 194

JO - Journal of Personality Disorders

JF - Journal of Personality Disorders

SN - 0885-579X

IS - 2

ER -